ONCIMMUNE HOLDINGS PLC Logo

ONCIMMUNE HOLDINGS PLC

Immunodiagnostics company specializing in antibody and autoantibody biomarker signatures.

ONC | IL

Overview

Corporate Details

ISIN(s):
GB00BYQ94H38
LEI:
213800HCYIWT6YPI1I02
Country:
United Kingdom
Address:
CLINICAL SCIENCES BUILDING CITY HOSPITAL, NG5 1PB NOTTINGHAM

Description

Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-26 13:45
Appointment of Administrators & Nomad Resignation
English 9.0 KB
2025-03-19 08:00
Holding(s) in Company
English 22.0 KB
2025-03-17 08:00
Intention to Appoint Administrators and Suspension
English 11.4 KB
2025-03-14 08:00
Block Listing Return
English 12.3 KB
2025-03-10 14:39
Result of GM
English 14.5 KB
2025-02-27 17:18
Result of AGM
English 13.5 KB
2025-02-24 08:00
Strategic update
English 11.1 KB
2025-02-18 08:00
Holding(s) in Company
English 23.3 KB
2025-02-12 08:01
Block Listing Return
English 12.3 KB
2025-02-12 08:00
Posting of Notice of General Meeting
English 8.1 KB
2025-02-10 08:00
Final Results
English 154.5 KB
2025-02-04 11:38
Holding(s) in Company
English 23.2 KB
2025-02-03 08:00
Notice of Annual General Meeting
English 8.2 KB
2025-01-31 08:00
Trading Update
English 13.6 KB
2024-12-10 16:36
Holding(s) in Company
English 23.2 KB

Automate Your Workflow. Get a real-time feed of all ONCIMMUNE HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ONCIMMUNE HOLDINGS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ONCIMMUNE HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.